| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032513A1 Protein binding polypeptides |
| 07/01/1999 | WO1999032148A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | WO1999032133A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections |
| 07/01/1999 | WO1999025832A8 Toso |
| 07/01/1999 | WO1999020747A3 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | DE19752855A1 Retrovirale Pseudotyp-Vektoren mit modifizierten Oberflächen-Hüllproteinen und Verfahren zu ihrer Herstellung für den selektiven Gentransfer Retroviral vectors pseudotyped with modified surface envelope proteins and methods for their preparation for selective gene transfer |
| 07/01/1999 | DE19752854A1 Cell-specific retroviral vectors with antibody domains suitable for cell-specific transduction of selected mammal cell types |
| 07/01/1999 | CA2316034A1 Sigirr dna and polypeptides |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315942A1 Tigirr dna and polypeptides |
| 07/01/1999 | CA2315788A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315301A1 Protein binding polypeptides |
| 07/01/1999 | CA2315280A1 Method for quantifying denatured ldl |
| 07/01/1999 | CA2315037A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | CA2314614A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 07/01/1999 | CA2311416A1 Prostate cancer gene |
| 07/01/1999 | CA2309391A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 07/01/1999 | CA2303483A1 Sag: sensitive to apoptosis gene |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926157A1 Protein capable of combining with tbp to form complex, polynucleotide coding for said protein, anti-sense polynucleotide of said polynucleotide, and antibody capable of recognizing said protein |
| 06/30/1999 | EP0926155A2 Polypeptides from the N-terminal domain of gp116 of cytomegalovirus and their diagnostic, prophylactic and therapeutic use |
| 06/30/1999 | EP0925503A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 06/30/1999 | EP0925502A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 06/30/1999 | EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 06/30/1999 | EP0925358A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925305A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 06/30/1999 | EP0925304A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 06/30/1999 | EP0925073A1 $i(STAPHYLOCOCCUS AUREUS) ANTIGEN |
| 06/30/1999 | CN1221452A Hybrid interferon compositions and method of use |
| 06/30/1999 | CN1221450A Spruce bunworm antifreeze proteins, genes and methods of using the same |
| 06/30/1999 | CN1221428A Cellular internalization of PIGR large biological molecule characteristic high structure and associated ligands |
| 06/30/1999 | CN1221349A Cellular vaccines immunotherapeutics and methods for their preparation |
| 06/29/1999 | US5917126 Saccharose phosphate synthetase (SPS), a preparation method and CDNA therefor, and use of the CDNA for modifying SPS expression in plant cells |
| 06/29/1999 | US5917030 Platelet cell adhesion molecule and variants thereof |
| 06/29/1999 | US5917027 Nucleic acids encoding potassium-channel proteins |
| 06/29/1999 | US5917021 Stabilized monomeric protein compositions |
| 06/29/1999 | US5917018 Method for producing correctly folded proteins from a mixture of misfolded proteins, e.g. bacterial inclusion-body aggregates |
| 06/29/1999 | US5917017 Diphtheria toxin vaccines bearing a mutated R domain |
| 06/29/1999 | US5916871 Inhibitory factor |
| 06/29/1999 | US5916805 Antithrombotic agent and anti-von Willebrand factor monoclonal antibody |
| 06/29/1999 | US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells. |
| 06/29/1999 | US5916772 The dna encoding saporin and dna encoding the n-terminal extension are selected such that saporin-containing protein is cytotoxic upon internalization by selected cells. |
| 06/29/1999 | US5916771 One advantage of the method of the invention is that cells expressing a single component of the final multi-component protein can be individually selected for one or more desired characteristics, such as a high rate of production. |
| 06/29/1999 | US5916769 Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides |
| 06/29/1999 | US5916768 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 06/29/1999 | US5916766 Human marco scavenger receptor |
| 06/29/1999 | US5916755 Relates to genes which encode novel proteins related to a family of receptor proteins typified by two related membrane spanning tyrosine kinases: the epidermal growth factor receptor, which is encoded by the erbb gene, and the receptor |
| 06/29/1999 | US5916572 Chagas' disease |
| 06/29/1999 | US5916563 Parvovirus protein presenting capsids |
| 06/29/1999 | US5916561 Monoclonal antibody against CD44v6 |
| 06/29/1999 | US5916560 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith |
| 06/29/1999 | US5916559 For organ transplants |
| 06/29/1999 | US5916558 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 06/29/1999 | US5916556 Human MRNA editing enzyme |
| 06/29/1999 | CA2125974C Senescent cell derived inhibitors of dna synthesis |
| 06/29/1999 | CA2062959C Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin |
| 06/29/1999 | CA1340612C Cell specific cytotoxic agents derived from diphtheria toxin |
| 06/29/1999 | CA1340610C Monoclonal antibody to polymorphic hla determinant-b27 |
| 06/24/1999 | WO1999031510A1 β(1-3)-GLUCAN DIAGNOSTIC ASSAYS |
| 06/24/1999 | WO1999031274A2 Reagents and methods useful for detecting diseases of the pancreas |
| 06/24/1999 | WO1999031256A2 Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis |
| 06/24/1999 | WO1999031252A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | WO1999031246A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 06/24/1999 | WO1999031241A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 06/24/1999 | WO1999031236A2 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 06/24/1999 | WO1999031234A1 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means |
| 06/24/1999 | WO1999031233A1 Polypeptides, polynucleotides and uses thereof |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031231A1 p53 REGULATORY PROTEIN CALLED RB18A AND USES THEREOF |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999031229A2 Peptides and nucleic acids derived from eisenia foetida and the use thereof |
| 06/24/1999 | WO1999031225A2 Human phosphatases |
| 06/24/1999 | WO1999031140A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/24/1999 | WO1999031139A1 Novel monoclonal antibodies and utilization thereof |
| 06/24/1999 | WO1999031134A1 Glucose regulated gene |
| 06/24/1999 | WO1999031133A1 Novel abc transporter |
| 06/24/1999 | WO1999031132A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS) |
| 06/24/1999 | WO1999031131A2 Mammalian calcitonin-like polypeptide-1 |
| 06/24/1999 | WO1999031128A2 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | WO1999031117A1 110 human secreted proteins |
| 06/24/1999 | WO1999031116A1 Human dendriac and brainiac-3 |
| 06/24/1999 | WO1999030738A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | WO1999030735A1 UGC (UPSTREAM GENE OF cdsA) |
| 06/24/1999 | WO1999030700A1 Immunoglobulin-rich milk, production and use thereof |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | WO1999020654A3 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT |
| 06/24/1999 | WO1999019490A9 Apo-3 ligand |
| 06/24/1999 | WO1999019480A3 Human receptor proteins; related reagents and methods |
| 06/24/1999 | WO1999019359A9 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | WO1999015692A3 Dengue virus antigens and treatment of dengue fever |
| 06/24/1999 | WO1997030158A9 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 06/24/1999 | DE19830914C1 Preparation of a protein solution, especially albumin solution for use as blood volume substitute in emergency situations, and solution containing blood coagulation factors |
| 06/24/1999 | DE19754815A1 Preparation of leptin-alpha2-macroglobulin complexes, for diagnostic and therapeutic purposes |
| 06/24/1999 | CA2730373A1 Treatment of cancer having overexpression of erbb2 with anti-erbb2 antibodies and a hormonal chemotherapeutic agent |